BIROn - Birkbeck Institutional Research Online

    Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis.

    Maitra, A. and Evangelopoulos, D. and Chrzastek, A. and Martin, L.T. and Hanrath, A. and Chapman, E. and Hailes, H.C. and Lipman, M. and McHugh, T.D. and Waddell, S.J. and Bhakta, Sanjib (2020) Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis. The Journal of Antimicrobial Chemotherapy , ISSN 1460-2091.

    [img]
    Preview
    Text
    40641.pdf - Published Version of Record
    Available under License Creative Commons Attribution.

    Download (670kB) | Preview

    Abstract

    The rise of antimicrobial drug resistance in Mycobacterium tuberculosis coupled with the shortage of new antibiotics has elevated TB to a major global health priority. Repurposing drugs developed or used for other conditions has gained special attention in the current scenario of accelerated drug development for several global infectious diseases. In a similar effort, previous studies revealed that carprofen, a non-steroidal anti-inflammatory drug, selectively inhibited the growth of replicating, non-replicating and MDR clinical isolates of M. tuberculosis. We aimed to reveal the whole-cell phenotypic and transcriptomic effects of carprofen in mycobacteria. Integrative molecular and microbiological approaches such as resazurin microtitre plate assay, high-throughput spot-culture growth inhibition assay, whole-cell efflux inhibition, biofilm inhibition and microarray analyses were performed. Analogues of carprofen were also synthesized and assessed for their antimycobacterial activity. Carprofen was found to be a bactericidal drug that inhibited mycobacterial drug efflux mechanisms. It also restricted mycobacterial biofilm growth. Transcriptome profiling revealed that carprofen likely acts by targeting respiration through the disruption of membrane potential. The pleiotropic nature of carprofen's anti-TB action may explain why spontaneous drug-resistant mutants could not be isolated in practice. This immunomodulatory drug and its chemical analogues have the potential to reverse TB antimicrobial drug resistance, offering a swift path to clinical trials of novel TB drug combinations. [Abstract copyright: © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.]

    Metadata

    Item Type: Article
    School: School of Science > Biological Sciences
    SWORD Depositor: Mr Joe Tenant
    Depositing User: Administrator
    Date Deposited: 01 Sep 2020 16:07
    Last Modified: 16 Oct 2020 09:39
    URI: https://eprints.bbk.ac.uk/id/eprint/40641

    Statistics

    Downloads
    Activity Overview
    33Downloads
    29Hits

    Additional statistics are available via IRStats2.

    Archive Staff Only (login required)

    Edit/View Item Edit/View Item